CRH (CRH) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
21 Dec, 2025Executive summary
Achieved record Q3 2025 results with revenues of $11.1 billion, Adjusted EBITDA up 10% to $2.7 billion, and net income up 9% to $1.5 billion, driven by strong demand, pricing momentum, and acquisitions.
Raised the midpoint of full-year adjusted EBITDA guidance to $7.65 billion, reflecting 10% year-over-year growth and another record year.
Completed 27 acquisitions year-to-date, investing $3.5 billion, and returned $1.8 billion to shareholders via dividends and buybacks.
Strategy and connected portfolio expected to deliver continued growth, supported by megatrends in infrastructure, transportation, water, and reindustrialization.
Financial highlights
Q3 2025 revenues reached $11.1 billion, up 5% year-over-year; Adjusted EBITDA was $2.7 billion, up 10%; Adjusted EBITDA margin improved by 100bps to 24.3%; Diluted EPS rose 12% to $2.21.
Net income for Q3 2025 was $1.52 billion, up from $1.39 billion in Q3 2024; net income margin increased to 13.7%.
Declared a quarterly dividend of $0.37 per share, a 6% increase year-over-year.
Year-to-date, $6.5 billion deployed in growth investments and shareholder returns, including $1.2 billion in growth capex, $0.7 billion in dividends, and $1.1 billion in share repurchases.
Outlook and guidance
Full-year 2025 adjusted EBITDA expected between $7.6–$7.7 billion, net income $3.8–$3.9 billion, and diluted EPS $5.49–$5.72.
2026 outlook remains positive, supported by public infrastructure investment, robust backlogs, and resilient repair/remodel activity.
Capital expenditure guidance for 2025 set at $2.7–$2.8 billion.
M&A expected to contribute roughly $200 million incremental EBITDA in 2026.
Latest events from CRH
- Record financials, capital structure simplification, and key governance proposals for 2026 AGM.CRH
Proxy Filing13 Mar 2026 - Delisting and preference share cancellations aim to simplify capital structure and cut costs.CRH
Proxy Filing13 Mar 2026 - Record 2025 financials, double-digit EBITDA growth, and strong 2026 outlook on infrastructure demand.CRH
Q4 202519 Feb 2026 - Q2 net income up 8%, EBITDA up 12%, margins expanded, and FY24 guidance raised.CRH
H1 20242 Feb 2026 - Q3 saw strong sales, margin gains, and M&A, with a positive outlook reaffirmed.CRH
Q3 2024 TU16 Jan 2026 - Double-digit profit growth and margin expansion achieved, with strong 2025 outlook.CRH
H2 20247 Jan 2026 - Record financials, new equity plan, governance updates, and strong ESG progress headline the proxy.CRH
Proxy Filing2 Dec 2025 - Record results, NYSE transition, new CEO, and 12 key AGM proposals mark a transformative year.CRH
Proxy Filing2 Dec 2025 - Definitive additional proxy materials filed for upcoming shareholder meeting.CRH
Proxy Filing2 Dec 2025